| 000 | 01535 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513071022.0 | ||
| 264 | 0 | _c19940204 | |
| 008 | 199402s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00078a018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBock, M G | |
| 245 | 0 | 0 |
_aDevelopment of 1,4-benzodiazepine cholecystokinin type B antagonists. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cDec 1993 |
||
| 300 |
_a4276-92 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzodiazepines _xchemical synthesis |
| 650 | 0 | 4 |
_aBenzodiazepinones _xchemical synthesis |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aCerebral Cortex _xmetabolism |
| 650 | 0 | 4 | _aDevazepide |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPancreas _xmetabolism |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Cholecystokinin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSincalide _xmetabolism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aDiPardo, R M | |
| 700 | 1 | _aEvans, B E | |
| 700 | 1 | _aRittle, K E | |
| 700 | 1 | _aWhitter, W L | |
| 700 | 1 | _aGarsky, V M | |
| 700 | 1 | _aGilbert, K F | |
| 700 | 1 | _aLeighton, J L | |
| 700 | 1 | _aCarson, K L | |
| 700 | 1 | _aMellin, E C | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 36 _gno. 26 _gp. 4276-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00078a018 _zAvailable from publisher's website |
| 999 |
_c8276792 _d8276792 |
||